Risk factors for parvovirus B19 infection in pregnancy

被引:117
作者
Valeur-Jensen, AK
Pedersen, CB
Westergaard, T
Jensen, IP
Lebech, M
Andersen, PK
Aaby, P
Pedersen, BN
Melbye, M
机构
[1] Danish Epidemiol Sci Ctr, Dept Epidemiol Res, Copenhagen, Denmark
[2] State Serum Inst, Dept Virol, Copenhagen, Denmark
[3] State Serum Inst, Dept Clin Biochem, Copenhagen, Denmark
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 281卷 / 12期
关键词
D O I
10.1001/jama.281.12.1099
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Parvovirus B19 infection during pregnancy has been associated with fetal death. However, the incidence of and risk factors for infection in pregnant women have not been well studied. Objectives To estimate a pregnant woman's risk of infection with parvovirus B19 in epidemic and endemic situations and to study risk factors for infection. Design Population-based cohort study conducted between November 1992 and June 1994. Setting Three regions in Denmark. Participants A total of 30 946 pregnant women from a consecutive and population-based screening. Main Outcome Measures Specific IgG antibodies in serum samples obtained in the first trimester of pregnancy and from the newborn infant to assess past infection and seroconversion. Information on family structure, educational background, socioeconomic status, and pregnancy outcome was obtained from national registers. Results Based on 30 946 serum samples, 65.0% of pregnant women had evidence of past infection. Annual seroconversion rates among susceptible women during endemic and epidemic periods were 1.5% (95% confidence interval [CI], 0.2%-1.9%) and 13.0% (95% CI, 8.7%-23.1%), respectively. Baseline seropositivity was significantly correlated with increasing number of siblings, having a sibling of the same age, number of own children, and occupational exposure to children. Risk of acute infection increased with the number of children in the household as follows: 0 children odds ratio (OR), 1 (reference); 1 child OR, 3.17 (95% CI, 2.24-4.49); 2 children OR, 5.47 (95% CI, 3.55-8.45); 3 or more children OR, 7.54 (95% CI, 3.80-14.94). Having children aged 6 to 7 years resulted in the highest rate of seroconversion among mothers (6.8%; OR, 4.07; 95% CI, 1.89-8.73). Compared with other pregnant women, nursery school teachers had a 3-fold increased risk of acute infection (OR, 3.09; 95% CI, 1.62-5.89). Population-attributable risk of seroconversion was 55.4% for number of own children and 6.0% for occupational exposure. Conclusions The risk of infection is high for susceptible pregnant women during epidemics and associated with the level of contact with children. Nursery school teachers have the highest occupational risk, but most infections seem to be the result of exposure to the woman's own children.
引用
收藏
页码:1099 / 1105
页数:7
相关论文
共 30 条
  • [11] OCCUPATIONAL RISK-FACTORS FOR INFECTION WITH PARVOVIRUS B19 AMONG PREGNANT-WOMEN
    CARTTER, ML
    FARLEY, TA
    ROSENGREN, S
    QUINN, DL
    GILLESPIE, SM
    GARY, GW
    HADLER, JL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) : 282 - 285
  • [12] THE ROLE OF PARVOVIRUS-B19 IN APLASTIC CRISIS AND ERYTHEMA INFECTIOSUM (5TH DISEASE)
    CHORBA, T
    COCCIA, P
    HOLMAN, RC
    TATTERSALL, P
    ANDERSON, LJ
    SUDMAN, J
    YOUNG, NS
    KURCZYNSKI, E
    SAARINEN, UM
    MOIR, R
    LAWRENCE, DN
    JASON, JM
    EVATT, B
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (03) : 383 - 393
  • [13] FORTNIGHTLY REVIEW - PARVOVIRUS B19 - AN EXPANDING SPECTRUM OF DISEASE
    COHEN, B
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7019): : 1549 - 1552
  • [14] THE PREVALENCE OF ANTIBODY TO HUMAN PARVOVIRUS-B19 IN ENGLAND AND WALES
    COHEN, BJ
    BUCKLEY, MM
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1988, 25 (02) : 151 - 153
  • [15] COHEN BJ, 1993, J PUBLIC HEALTH MED, V15, P281
  • [16] ELSHUBINGER AM, 1996, ZENTRALBL BAKTERIOL, V284, P232
  • [17] OCCUPATIONAL RISK OF HUMAN PARVOVIRUS-B19 INFECTION FOR SCHOOL AND DAY-CARE PERSONNEL DURING AN OUTBREAK OF ERYTHEMA-INFECTIOSUM
    GILLESPIE, SM
    CARTTER, ML
    ASCH, S
    ROKOS, JB
    GARY, GW
    TSOU, CJ
    HALL, DB
    ANDERSON, LJ
    HURWITZ, ES
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (15): : 2061 - 2065
  • [18] THE INCIDENCE OF HUMAN PARVOVIRUS B19 INFECTION DURING PREGNANCY AND ITS IMPACT ON PERINATAL OUTCOME
    GRATACOS, E
    TORRES, PJ
    VIDAL, J
    ANTOLIN, E
    COSTA, J
    DEANTA, MTJ
    CARARACH, V
    ALONSO, PL
    FORTUNY, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) : 1360 - 1363
  • [19] HALL SM, 1990, BMJ-BRIT MED J, V300, P1166
  • [20] Prospective evaluation of 618 pregnant women exposed to parvovirus B19: Risks and symptoms
    Harger, JH
    Adler, SP
    Koch, WC
    Harger, GF
    [J]. OBSTETRICS AND GYNECOLOGY, 1998, 91 (03) : 413 - 420